Inventor · disambiguated record
Olaf Mundigl
Also filed as: MUNDIGL OLAF
36 granted patents·7 pending applications·231 citations·filing 2001–2024
97Inventor score
Top patents by PatentIndex Score
43 records- 0192US9890209B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Feb 13, 2018·10 cites·8 claims
- 0292US9290567B2Use of an anti-Tau pS422 antibody for the treatment of brain diseasesHOFFMANN LA ROCHE·Filed 2013·Granted Mar 22, 2016·25 cites·2 claims
- 0392US7572897B2Antibodies against insulin-like growth factor I receptor and uses thereofHOFFMANN LA ROCHE·Filed 2007·Granted Aug 11, 2009·19 cites·6 claims
- 0491US10822402B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Nov 3, 2020·4 cites·12 claims
- 0590US8609097B2Use of an anti-Tau pS422 antibody for the treatment of brain diseasesBOHRMANN BERND·Filed 2010·Granted Dec 17, 2013·28 cites·10 claims
- 0689US10806795B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2019·Granted Oct 20, 2020·3 cites·17 claims
- 0788US9670274B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Jun 6, 2017·6 cites·8 claims
- 0888US9493553B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Nov 15, 2016·8 cites·8 claims
- 0987US8907069B2Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agentBRINKMANN ULRICH·Filed 2010·Granted Dec 9, 2014·7 cites·17 claims
- 1086US7098241B2Thiophene hydroxamic acid derivativesHOFFMANN LA ROCHE·Filed 2003·Granted Aug 29, 2006·27 cites·34 claims
- 1185US11273223B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2020·Granted Mar 15, 2022·1 cites·28 claims
- 1285US9862763B2Humanized anti-tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Jan 9, 2018·4 cites·13 claims
- 1384US12297263B2Humanized anti-Tau(PS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2022·Granted May 13, 2025·0 cites·6 claims
- 1484US6627439B2Antibodies against SEMP1(p23)HOFFMANN LA ROCHE·Filed 2001·Granted Sep 30, 2003·26 cites·6 claims
- 1583US10730938B2Bispecific antibodies and methods of use in ophthalmologyHOFFMANN LA ROCHE·Filed 2017·Granted Aug 4, 2020·3 cites·13 claims
- 1683US10344085B2Anti-IL-1beta antibodiesHOFFMANN LA ROCHE·Filed 2017·Granted Jul 9, 2019·5 cites·9 claims
- 1782US10561737B2Bispecific anti-hapten/anti-blood brain barrier receptor antibodies, complexes thereof and their use as blood brain barrier shuttlesHOFFMANN LA ROCHE·Filed 2014·Granted Feb 18, 2020·4 cites·17 claims
- 1882US9562091B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2014·Granted Feb 7, 2017·4 cites·10 claims
- 1982US9050375B2Bi-specific digoxigenin binding antibodiesBRAMLAGE BIRGIT·Filed 2010·Granted Jun 9, 2015·6 cites·17 claims
- 2082US7378503B2Antibodies against insulin-like growth factor 1 receptor and uses thereofHOFFMANN LA ROCHE·Filed 2004·Granted May 27, 2008·13 cites·10 claims
- 2180US10465000B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2016·Granted Nov 5, 2019·2 cites·6 claims
- 2279US2024101657A1Antibody that binds to vegf and il-1beta and methods of useHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 2376US7579157B2Antibody selection method against IGF-IRHOFFMANN LA ROCHE·Filed 2004·Granted Aug 25, 2009·7 cites·1 claims
- 2476US6800638B2Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitorsHOFFMANN LA ROCHE·Filed 2001·Granted Oct 5, 2004·10 cites·7 claims
- 2575US10087246B2Anti-PDGF-B antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Oct 2, 2018·2 cites·14 claims
- 2673US11866490B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2021·Granted Jan 9, 2024·0 cites·36 claims
- 2772US11572404B2Humanized anti-Tau(pS422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2020·Granted Feb 7, 2023·0 cites·6 claims
- 2871US11130804B2Antibody that binds to VEGF and IL-1beta and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted Sep 28, 2021·0 cites·28 claims
- 2970US10647761B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2019·Granted May 12, 2020·0 cites·8 claims
- 3069US7091229B2Tricyclic lactam and sultam derivatives and their use as histone deacetylase inhibitorsHOFFMANN LA ROCHE·Filed 2002·Granted Aug 15, 2006·4 cites·8 claims
- 3167US9574016B2Complex of bi-specific antibody and digoxigenin conjugated to a therapeutic or diagnostic agentHOFFMANN LA ROCHE·Filed 2014·Granted Feb 21, 2017·0 cites·8 claims
- 3266US8623666B2Method for detecting erythropoietin (EPO) receptor using anti-human EPO receptor antibodiesJARSCH MICHAEL·Filed 2012·Granted Jan 7, 2014·1 cites·10 claims
- 3365US9309306B2Anti-MCSP antibodiesFREYTAG OLIVIER·Filed 2012·Granted Apr 12, 2016·1 cites·21 claims
- 3465US2020223912A1Humanized anti-tau(ps422) antibodies and methods of useHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 3564US2025034269A1Agonistic ltbr antibodies and bispecific antibodies comprising themHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 3663US10316082B2Anti-alpha-synuclein antibodies and methods of useHOFFMANN LA ROCHE·Filed 2017·Granted Jun 11, 2019·0 cites·8 claims
- 3762US2009275126A1Antibodies against insulin-like growth factor i receptor and uses thereofGRAUS YVO·Filed 2009·Application pending·0 cites
- 3861US10562973B2Blood-brain barrier shuttles containing antibodies recognizing alpha-synucleinPROTHENA BIOSCIENCE LTD·Filed 2015·Granted Feb 18, 2020·1 cites·40 claims
- 3958US9187563B2Anti-human EPO receptor antibodies and methods of useHOFFMANN LA ROCHE·Filed 2013·Granted Nov 17, 2015·0 cites·15 claims
- 4056US2011165592A1Antibodies against human epo receptorHOFFMANN LA ROCHE·Filed 2009·Application pending·0 cites
- 4152US2020299397A1Blood-Brain Barrier Shuttles Containing Antibodies Recognizing Alpha-SynucleinPROTHENA BIOSCIENCE LTD·Filed 2020·Application pending·0 cites
- 4244US2011143372A1Antibodies against human epo receptorHOFFMANN LA ROCHE·Filed 2011·Application pending·0 cites
- 4338US9221909B2Antibodies against human EPO receptorJARSCH MICHAEL·Filed 2010·Granted Dec 29, 2015·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Olaf Mundigl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →